Evidence map›Paper›PMID 29385212›Full record

ArticlePLoS pathogens2018

Recombinant PrPSc shares structural features with brain-derived PrPSc: Insights from limited proteolysis.

Alejandro M Sevillano, Natalia Fernández-Borges, Neelam Younas, Fei Wang, Saioa R Elezgarai, Susana Bravo, Ester Vázquez-Fernández, Isaac Rosa, Hasier Eraña, David Gil and 9 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Immunotherapy against Prion Disease.Pathogens (Basel, Switzerland) · 2020
    Review
  5. Article
  6. Modeling PrPFrontiers in bioengineering and biotechnology · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Alejandro M SevillanoCIMUS Biomedical Research Institute and Department of Medical Sciences University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain.ORCID 0000-0002-2107-2375
Natalia Fernández-BorgesCIC bioGUNE, Derio, Spain.
Neelam YounasCIMUS Biomedical Research Institute and Department of Medical Sciences University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain.ORCID 0000-0003-0421-5247
Fei WangCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, United States of America.
Saioa R ElezgaraiCIC bioGUNE, Derio, Spain.ORCID 0000-0001-7054-9689
Susana BravoProteomics Lab, IDIS, Santiago de Compostela, Spain.
Ester Vázquez-FernándezCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Canada.
Isaac RosaCIMUS Biomedical Research Institute and Department of Medical Sciences University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain.
Hasier ErañaCIC bioGUNE, Derio, Spain.ORCID 0000-0001-8776-4211
David GilCIC bioGUNE, Derio, Spain.ORCID 0000-0003-4241-1302
Sonia VeigaCIMUS Biomedical Research Institute and Department of Medical Sciences University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain.
Enric VidalPriocat Laboratory, Centre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Barcelona, Catalonia, Spain.ORCID 0000-0002-4965-3286
Melissa L Erickson-BeltranUSDA, ARS Western Regional Research Center, Albany, California, United States of America.ORCID 0000-0002-0505-9568
Esteban GuitiánMass spectrometry Core Facility, RIAIDT, University of Santiago de Compostela, Santiago de Compostela, Spain.
Christopher J SilvaUSDA, ARS Western Regional Research Center, Albany, California, United States of America.
Romolo NonnoDepartment of Veterinary Public Health and Food Safety, Istituto Superiore di Sanità, Rome, Italy.
Jiyan MaCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, United States of America.
Joaquín CastillaCIC bioGUNE & IKERBasque, Bizkaia, Spain.ORCID 0000-0002-2216-1361
Jesús R RequenaCIMUS Biomedical Research Institute and Department of Medical Sciences University of Santiago de Compostela-IDIS, Santiago de Compostela, Spain.

Funding

To investigate the contributions of lipid membranes to prion diseaseR01NS060729 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI MA, JIYAN, SUREWICZ, WITOLD K · 2008 to 2017
$4.5M
NINDS NIH HHS R01 NS060729
6 · The paper itself

Abstract

Very solid evidence suggests that the core of full length PrPSc is a 4-rung β-solenoid, and that individual PrPSc subunits stack to form amyloid fibers. We recently used limited proteolysis to map the β-strands and connecting loops that make up the PrPSc solenoid. Using high resolution SDS-PAGE followed by epitope analysis, and mass spectrometry, we identified positions ~116/118, 133-134, 141, 152-153, 162, 169 and 179 (murine numbering) as Proteinase K (PK) cleavage sites in PrPSc. Such sites likely define loops and/or borders of β-strands, helping us to predict the threading of the β-solenoid. We have now extended this approach to recombinant PrPSc (recPrPSc). The term recPrPSc refers to bona fide recombinant prions prepared by PMCA, exhibiting infectivity with attack rates of ~100%. Limited proteolysis of mouse and bank vole recPrPSc species yielded N-terminally truncated PK-resistant fragments similar to those seen in brain-derived PrPSc, albeit with varying relative yields. Along with these fragments, doubly N- and C-terminally truncated fragments, in particular ~89/97-152, were detected in some recPrPSc preparations; similar fragments are characteristic of atypical strains of brain-derived PrPSc. Our results suggest a shared architecture of recPrPSc and brain PrPSc prions. The observed differences, in particular the distinct yields of specific PK-resistant fragments, are likely due to differences in threading which result in the specific biochemical characteristics of recPrPSc. Furthermore, recombinant PrPSc offers exciting opportunities for structural studies unachievable with brain-derived PrPSc.

Indexed as

ProteolysisAnimalsArvicolinaeBrainFemaleMiceMice, TransgenicPrionsProtein Structure, SecondaryPrPSc ProteinsRecombinant ProteinsPrionsPrPSc ProteinsRecombinant Proteins

Identifiers

PMID29385212
PMCPMC5809102

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.